PAGAN, ELEONORA
 Distribuzione geografica
Continente #
AS - Asia 4.720
NA - Nord America 4.409
EU - Europa 2.746
SA - Sud America 651
AF - Africa 101
OC - Oceania 18
Totale 12.645
Nazione #
US - Stati Uniti d'America 4.318
SG - Singapore 1.557
VN - Vietnam 1.160
CN - Cina 700
IT - Italia 692
DE - Germania 639
HK - Hong Kong 630
BR - Brasile 490
RU - Federazione Russa 426
SE - Svezia 252
IE - Irlanda 174
FR - Francia 153
IN - India 133
ID - Indonesia 105
GB - Regno Unito 92
KR - Corea 70
AR - Argentina 66
FI - Finlandia 58
BD - Bangladesh 56
CA - Canada 53
TR - Turchia 43
JP - Giappone 42
NL - Olanda 39
UA - Ucraina 39
IQ - Iraq 34
PK - Pakistan 34
AT - Austria 30
ZA - Sudafrica 29
EC - Ecuador 27
ES - Italia 24
MX - Messico 24
PL - Polonia 24
DK - Danimarca 23
SA - Arabia Saudita 23
CH - Svizzera 21
CO - Colombia 21
PH - Filippine 19
IR - Iran 16
AU - Australia 15
PY - Paraguay 14
TN - Tunisia 14
ET - Etiopia 12
RO - Romania 11
EG - Egitto 9
LB - Libano 9
MY - Malesia 9
PE - Perù 9
UZ - Uzbekistan 9
BG - Bulgaria 8
CL - Cile 8
CZ - Repubblica Ceca 8
KE - Kenya 8
TH - Thailandia 8
TW - Taiwan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
MA - Marocco 7
BO - Bolivia 6
IL - Israele 6
JO - Giordania 6
KG - Kirghizistan 6
BE - Belgio 5
DZ - Algeria 5
GR - Grecia 5
KZ - Kazakistan 5
LT - Lituania 5
PS - Palestinian Territory 5
SN - Senegal 5
CR - Costa Rica 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GH - Ghana 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
HN - Honduras 1
MU - Mauritius 1
Totale 12.638
Città #
Ann Arbor 819
Singapore 798
Hong Kong 608
Frankfurt am Main 530
Ashburn 373
Ho Chi Minh City 337
San Jose 270
Fairfield 259
Hanoi 247
Wilmington 212
Milan 190
Dublin 164
Dallas 150
Houston 141
Santa Clara 134
Hefei 126
Chicago 120
Chandler 116
New York 112
Seattle 107
Beijing 95
Los Angeles 95
Woodbridge 94
The Dalles 92
Princeton 88
Jakarta 86
Cambridge 78
Lauterbourg 61
Moscow 56
Dearborn 54
Dong Ket 49
Seoul 49
Altamura 45
Lawrence 43
Shanghai 43
San Diego 40
Helsinki 38
Da Nang 34
Guangzhou 34
Nanjing 32
Haiphong 31
Biên Hòa 30
Buffalo 29
São Paulo 29
Ha Long 27
Munich 27
Tokyo 24
Council Bluffs 23
Nuremberg 23
Rome 20
Warsaw 20
Toronto 19
Hải Dương 18
London 18
Thái Nguyên 18
Jacksonville 17
Sacramento 17
Ardea 16
Quận Bình Thạnh 16
Mumbai 15
Zurich 15
Dhaka 14
Andover 13
Chennai 13
Kent 13
Quận Một 13
Vienna 13
Boardman 12
Lappeenranta 12
Naples 12
Rio de Janeiro 12
Seregno 12
Umeå 12
Baghdad 11
Carate Brianza 11
Hangzhou 11
Montreal 11
Monza 11
Paris 11
Salt Lake City 11
Addis Ababa 10
Belo Horizonte 10
Brasília 10
Jeddah 10
Orem 10
Bologna 9
Bắc Giang 9
Columbus 9
Johannesburg 9
Ninh Bình 9
Porto Alegre 9
Pune 9
Quito 9
Quận Phú Nhuận 9
Redmond 9
Stockholm 9
Tampa 9
Vinh 9
Atlanta 8
Bangkok 8
Totale 7.882
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 591
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 468
Laryngeal cancer mortality trends in European countries 365
Male breast cancer: a multicenter study to provide a guide for proper management 343
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes 341
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 318
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 291
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 282
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 279
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 270
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 267
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 263
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 259
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 252
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 247
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 241
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 226
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 212
Sex-based differences in cancer immunotherapy efficacy 210
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 200
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 200
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 199
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 198
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 198
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer 193
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 188
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 187
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 184
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports 178
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 174
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients 173
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 171
Comparative Efficacy of Classic Versus Horizontal Incision Techniques in Skin-Reducing Mastectomy: A Single Center Retrospective Analysis 169
Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media 167
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 167
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 166
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 161
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 161
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 155
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 155
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 154
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 150
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 146
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 146
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 143
Different Response to Immunotherapy According to Melanoma Histologic Subtype 141
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 140
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 140
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 135
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 135
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 132
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 131
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 128
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 127
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 125
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 116
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 115
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 113
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 109
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 103
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 103
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 101
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 99
Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer 98
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 97
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 96
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 85
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants 75
One-Year Mortality in Hospitalized, Frail Older Adults with Atrial Fibrillation on Oral Anticoagulant Therapy: Impact of Stroke and Bleeding Events 75
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials 60
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study 48
Effect of a Multimedia-Assisted Informed Consent Procedure on the Information Gain of Patients Undergoing Mastectomy and Implant-Based Reconstruction 39
Totale 13.074
Categoria #
all - tutte 43.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 0 0 0 0 64 45 182
2021/2022742 81 52 63 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/20252.649 129 306 135 132 159 138 164 93 296 329 307 461
2025/20265.524 846 772 520 575 544 261 818 325 437 426 0 0
Totale 13.074